Farther Finance Advisors’s Oragenics OGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$0 Hold
1
– – ﹤0.01% 6283
2026
Q2
$1 Hold
1
– – ﹤0.01% 5972
2026
Q1
$1 Buy
+1
New +$1 ﹤0.01% 5745
2025
Q3
– Sell
-1
Closed -$4 – 5041
2025
Q2
$4 Buy
+1
New +$5 ﹤0.01% 4472
2025
Q1
– Hold
0
– – – 4377

Farther Finance Advisors's OGEN Position: Q3 2026 in Review

Farther Finance Advisors held its Oragenics (OGEN) position steady in Q3 2026 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #6283.

Farther Finance Advisors first reported a position in OGEN in Q2 2025 and has held it in 4 quarters since. The position peaked at $4 in Q2 2025. 1 fund tracked by Wall St. Rank holds OGEN as of Q3 2026.

  • Farther Finance Advisors held 1 share of Oragenics worth $0 as of Q3 2026.
  • Farther Finance Advisors left its Oragenics share count unchanged in Q3 2026.
  • Oragenics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #6283 holding.
  • Farther Finance Advisors first reported a position in Oragenics in Q2 2025 and has held it in 4 quarters since.
  • Farther Finance Advisors's Oragenics position peaked at $4 in Q2 2025.
  • 1 fund tracked by Wall St. Rank held Oragenics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.